Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.


LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination
Authors: Fan-Lin Zeng, Jie Lin, Xing Xie, Yuan-Kang Xie, Jian-Hong Zhang, Daofeng Xu, Xiao He, Feng En Liu, Bin-Hui Xie
Neoplasma Vol.70, No.3, p. 361–374, 2023
Price: free access
[View Abstract]

A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1
Authors: Shuo Li, Fanggang Ren, Xiao-Li Liu, Hong-Yu Zhang, Zhi-Fang Xu, Daniel Muteb Muyey, Zhuanzhen Zheng, Yan-Hong Tan, Xiu-Hua Chen, Hong-Wei Wang
Neoplasma Vol.70, No.3, p. 350–360, 2023
Price: free access
[View Abstract]

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression
Authors: Guo-Fang Sun, Hao Ding
Neoplasma Vol.70, No.3, p. 340–349, 2023
Price: free access
[View Abstract]

Tumor-targeted suicide gene-directed enzyme prodrug therapy mediated by extracellular vesicles
Authors: Jana Jakubechova, Ursula Altanerova, Cestmir Altaner
Neoplasma Vol.70, No.3, p. 333–339, 2023
Price: free access
[View Abstract]

Function, drug resistance and prognostic effect of AKR1C2 in human cancer
Authors: Zhao Wang, Yue Feng, Jiayu Song, Di Sun, Yun-Yan Zhang
Neoplasma Vol.70, No.3, p. 319–332, 2023
Price: free access
[View Abstract]

Urinary shedding of common DNA viruses and their possible association with bladder cancer: a qPCR-based study
Neoplasma Vol.70, No.2, p. 311–318, 2023
Price: free access
[View Abstract]

Predicting the efficacy of immune checkpoint inhibitors monotherapy in advanced non-small cell lung cancer: a machine learning method based on multidimensional data
Authors: Na Liu, Bi-Lin Liang, Lu Lu, Bing-Qian Zhang, Jing-Jing Sun, Jian-Tao Yang, Jie Xu, Zheng-Bo Song, Lei Shi
Neoplasma Vol.70, No.2, p. 300–310, 2023
Price: free access
[View Abstract]

Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience
Authors: Tomáš Kříž, Alexandra Jungová, Daniel Lysák, Michal Karas, Marcela Hrabětová, Jiří Šrámek, Pavel Jindra
Neoplasma Vol.70, No.2, p. 294–299, 2023
Price: free access
[View Abstract]

Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia
Authors: Yue Wang, Deying Wang, Yao Wang, Haotian Yang, Guan Wang, Shuangshuang Wu
Neoplasma Vol.70, No.2, p. 287–293, 2023
Price: free access
[View Abstract]

NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway
Authors: Liao-Liao ZHU, Jing-Jie SHI, Yong-Dong GUO, Cheng YANG, Rong-Lin WANG, Shan-Shan LI, Dong-Xue GAN, Pei-Xiang MA, Jun-Qiang LI, Hai-Chuan SU
Neoplasma Vol.70, No.2, p. 272–286, 2023
Price: free access
[View Abstract]

The inhibition of Aurora A kinase regulates phospholipid remodeling by upregulating LPCAT1 in glioblastoma
Authors: Ya-Zhou MIAO, Jing WANG, Shu-Yu HAO, Yu-Xuan DENG, Zhe ZHANG, Ze-Ping JIN, Da-Yuan LIU, Shao-Dong ZHANG, Hong WAN, Nan JI, Jie FENG
Neoplasma Vol.70, No.2, p. 260–271, 2023
Price: free access
[View Abstract]

Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients
Authors: Lei Qian, Xiao Ding, Fang-Qi Li, Hui-Min Tian, Xiao Chen, Fu-Jun Han, Hong-Yi Wang, Wen-Qian Li, Chao Niu, Jian-Ting Xu, Zhao-Zhi Li, Hua He, Jiu-Wei Cui
Neoplasma Vol.70, No.2, p. 251–259, 2023
Price: free access
[View Abstract]

Transcriptional adaptor 3 influences the proliferative and invasive phenotypes of non-small cell lung cancer cells via regulating EMT
Authors: Li-Qin Xu, Shu-Wen Zhang, Rui Zhang, Jing-Jing Chen, Zai-Xin Yuan, Jian Feng, Jian-An Huang
Neoplasma Vol.70, No.2, p. 240–250, 2023
Price: free access
[View Abstract]

High expression of WTAP is related to poor prognosis in nasopharyngeal carcinoma
Authors: Chang-Juan Tao, Peng Zhang, Yuan-Yuan Chen, Ming Chen
Neoplasma Vol.70, No.2, p. 229–239, 2023
Price: free access
[View Abstract]

Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating PI3K/AKT/mTOR/GSK3β signaling pathway
Authors: Wen-Jing Zhu, Huan-Huan Huang, Yi-Fan Feng, Lei Zhan, Jian Yang, Lin Zhu, Qing-Yuan Wang, Bing Wei, Wen-Yan Wang
Neoplasma Vol.70, No.2, p. 216–228, 2023
Price: free access
[View Abstract]

Bigelovin inhibits hepatocellular carcinoma cell growth and metastasis by regulating the MAPT-mediated Fas/FasL pathway
Authors: Bei Wang, Chun-Hui Nie, Jun Xu, Da-Long Wan, Xiao Xu, Jiang-Juan He
Neoplasma Vol.70, No.2, p. 208–215, 2023
Price: free access
[View Abstract]

LINC00504 promotes the progression of acute myeloid leukemia by targeting MDM2
Authors: Jin-Hua Yan, Ling Yao, Ying Tan, Yue Wang
Neoplasma Vol.70, No.2, p. 199–207, 2023
Price: free access
[View Abstract]

Comprehensive analysis of the PTPN13 expression and its clinical implication in breast cancer
Authors: Jing-Ping Li, Xiang-Mei Zhang, Bei-Chen Liu, Shu-Guang Ren, Xiao-Han Zhao, Yun-Jiang Liu
Neoplasma Vol.70, No.2, p. 188–198, 2023
Price: free access
[View Abstract]

Challenges of in situ hybridization in miRNA analysis of triple-negative breast cancer morphological diversity
Authors: Markéta Kolečková, Michala Bezděková, Jan Bouchal, Mária Janíková, Júlia Bohošová, Ondřej Slabý, Marek Svoboda, Josef Srovnal, Katherine Vomáčková, Ivo Überall, Zdeněk Kolář
Neoplasma Vol.70, No.2, p. 179–187, 2023
Price: free access
[View Abstract]

Corrigendum: lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5
Authors: Fang ZHAO, Meng WANG, Yibin ZHANG, Rujuan SU, Chenyang HE, Xiao GAO, Ying ZAN, Shuqun ZHANG, Yuguang MA
Neoplasma Vol.70, No.1, p. 177–178, 2023
Price: free access
[View Abstract]

Display #  
Results 41 - 60 of 75

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.